Reference : ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kuf...
Scientific journals : Article
Life sciences : Biochemistry, biophysics & molecular biology
ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome.
Grünewald, Anne* [> >]
Arns, Bjorn* [> >]
Seibler, Philip [> >]
Rakovic, Aleksandar [> >]
Munchau, Alexander [> >]
Ramirez, Alfredo [> >]
Sue, Carolyn M. [> >]
Klein, Christine mailto [> >]
* These authors have contributed equally to this work.
Neurobiology of Aging
Yes (verified by ORBilu)
United States
[en] Adult ; Female ; Fibroblasts/metabolism ; Humans ; Male ; Mitochondria/genetics ; Mitochondrial Diseases/genetics ; Mutation/genetics ; Parkinsonian Disorders/genetics ; Proton-Translocating ATPases/genetics
[en] Mutations in ATP13A2 cause autosomal-recessive parkinsonism (Kufor-Rakeb syndrome; KRS). Because several other parkinsonism-associated proteins have been connected to mitochondrial function and mitophagy, we studied the impact of endogenous mutations in ATPase type 13A2 (ATP13A2) on mitochondria in fibroblasts from KRS patients compared with controls. In patients, we detected decreased adenosine triphosphate (ATP) synthesis rates, increased mitochondrial DNA levels, a higher frequency of mitochondrial DNA lesions, increased oxygen consumption rates, and increased fragmentation of the mitochondrial network. Importantly, overexpression of wild-type ATP13A2 rescued the respiration phenotype. These findings collectively suggest that ATP13A2 contributes to the maintenance of a healthy mitochondrial pool, supporting the hypothesis that impaired mitochondrial clearance represents an important pathogenic mechanism underlying KRS.
Researchers ; Students
Copyright (c) 2012 Elsevier Inc. All rights reserved.

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.